EU approves Gilead's HIV drug combo

02/24/2005 | iWon

Gilead Sciences reports it received European Commission approval to market its HIV drug Truvada in the European Union. Truvada combines two HIV drugs, Emtriva and Viread, in one pill, which can be taken once a day along with other antiretroviral medicines.

View Full Article in:

iWon

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA